The Natural History of Rheumatoid Arthritis
- PMID: 31196652
- DOI: 10.1016/j.clinthera.2019.04.028
The Natural History of Rheumatoid Arthritis
Abstract
Purpose: This article reviews the phases of rheumatoid arthritis (RA) development in terms of the evolution of disease, with a focus on events that occur before the first appearance of clinically apparent inflammatory arthritis. This presynovitis period is defined in individuals who eventually develop classified RA as the pre-RA phase. We include additional discussion of the relevance of this model of RA development to the concept of disease prevention.
Methods: The information provided in this review was identified through searches of the medical literature through MEDLINE and a review of references from published manuscripts as well as information obtained by the authors through attendance at various conferences and working groups related to pre-RA.
Findings: It is now well established that RA develops in a series of phases. The first of these phases is believed to be the presence of genetic and/or environmental risk factors for RA in the absence of detectable systemic autoimmunity in the blood. After this phase, autoimmunity may be detectable through a variety of means (eg, autoantibodies, autoreactive cells) in peripheral blood; in addition, there is emerging evidence that perhaps initiation and early propagation of RA-related autoimmunity may occur at mucosal sites. The presence of autoimmunity detectable in the blood through serologic or other testing is followed in most individuals by a propagation phase that is characterized by an expansion of autoimmunity, inflammation, and symptoms. This transition may be associated with similar or different genetic and environmental factors that initially triggered autoimmunity, as well as continued mucosal inflammation and local RA-related autoantibody production. Eventually, clinically detectable inflammatory arthritis develops that can be classified as RA.
Implications: Understanding the phases of RA development are critical to the development of preventive strategies for this disease.
Keywords: disease prevention; inflammatory arthritis; pre–rheumatoid arthritis; rheumatoid arthritis.
Copyright © 2019. Published by Elsevier Inc.
Similar articles
-
Mucosa Biology and the Development of Rheumatoid Arthritis: Potential for Prevention by Targeting Mucosal Processes.Clin Ther. 2019 Jul;41(7):1270-1278. doi: 10.1016/j.clinthera.2019.04.012. Epub 2019 Jun 10. Clin Ther. 2019. PMID: 31196643
-
Preclinical rheumatoid arthritis and rheumatoid arthritis prevention.Curr Opin Rheumatol. 2020 May;32(3):289-296. doi: 10.1097/BOR.0000000000000708. Curr Opin Rheumatol. 2020. PMID: 32205569 Free PMC article. Review.
-
Preclinical rheumatoid arthritis (autoantibodies): an updated review.Curr Rheumatol Rep. 2014 May;16(5):419. doi: 10.1007/s11926-014-0419-6. Curr Rheumatol Rep. 2014. PMID: 24643396 Free PMC article. Review.
-
Autoimmunity, inflammation, and dysbiosis mutually govern the transition from the preclinical to the clinical stage of rheumatoid arthritis.Immunol Res. 2018 Dec;66(6):696-709. doi: 10.1007/s12026-018-9048-x. Immunol Res. 2018. PMID: 30498956 Review.
-
Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis?Semin Arthritis Rheum. 2024 Feb;64S:152324. doi: 10.1016/j.semarthrit.2023.152324. Epub 2023 Nov 25. Semin Arthritis Rheum. 2024. PMID: 38030540
Cited by
-
Modification of the structural stability of human serum albumin in rheumatoid arthritis.PLoS One. 2023 Mar 17;18(3):e0271008. doi: 10.1371/journal.pone.0271008. eCollection 2023. PLoS One. 2023. PMID: 36930604 Free PMC article.
-
Translation Research in Therapeutic Approaches from Conventional to Novel Nano-therapeutics for Rheumatoid Arthritis Treatment.Curr Rheumatol Rev. 2025;21(1):37-53. doi: 10.2174/0115733971288433240408062359. Curr Rheumatol Rev. 2025. PMID: 38629371 Review.
-
Metabolites and metabolic pathways associated with rheumatoid arthritis and systemic lupus erythematosus.J Transl Autoimmun. 2022 Feb 28;5:100150. doi: 10.1016/j.jtauto.2022.100150. eCollection 2022. J Transl Autoimmun. 2022. PMID: 35257093 Free PMC article.
-
Endogenous antigens shape the transcriptome and TCR repertoire in an autoimmune arthritis model.J Clin Invest. 2024 Nov 26;135(2):e174647. doi: 10.1172/JCI174647. J Clin Invest. 2024. PMID: 39589811 Free PMC article.
-
Nano-platform Strategies of Herbal Components for the Management of Rheumatoid Arthritis: A Review on the Battle for Next-Generation Formulations.Curr Drug Deliv. 2024;21(8):1082-1105. doi: 10.2174/1567201821666230825102748. Curr Drug Deliv. 2024. PMID: 37622715 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical